Atlas Trials

SDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV Inhibitors

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch SDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV Inhibitors

RecordFirmDate
Functional Improvement of Progenitor Cells and Endothelial Function by Vildagliptin in Diabetes Mellitus (FINNjA-DM). (NCT00936234)Johann Wolfgang Goethe University Hospital2009-07-01

Track SDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV Inhibitors automatically

Every clearance here is in the API, with alerts when new ones post.